NO953050L - Anvendelse av neurotensin-antagonister for fremstilling av diuretiske medikamenter - Google Patents

Anvendelse av neurotensin-antagonister for fremstilling av diuretiske medikamenter

Info

Publication number
NO953050L
NO953050L NO953050A NO953050A NO953050L NO 953050 L NO953050 L NO 953050L NO 953050 A NO953050 A NO 953050A NO 953050 A NO953050 A NO 953050A NO 953050 L NO953050 L NO 953050L
Authority
NO
Norway
Prior art keywords
preparation
diuretic drugs
neurotensin antagonists
neurotensin
antagonists
Prior art date
Application number
NO953050A
Other languages
English (en)
Other versions
NO307737B1 (no
NO953050D0 (no
Inventor
Tiziano Croci
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Sa filed Critical Sanofi Sa
Publication of NO953050D0 publication Critical patent/NO953050D0/no
Publication of NO953050L publication Critical patent/NO953050L/no
Publication of NO307737B1 publication Critical patent/NO307737B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • G—PHYSICS
    • G07—CHECKING-DEVICES
    • G07F—COIN-FREED OR LIKE APPARATUS
    • G07F9/00—Details other than those peculiar to special kinds or types of apparatus
    • G07F9/001—Interfacing with vending machines using mobile or wearable devices
    • G—PHYSICS
    • G07—CHECKING-DEVICES
    • G07F—COIN-FREED OR LIKE APPARATUS
    • G07F9/00—Details other than those peculiar to special kinds or types of apparatus
    • G07F9/002—Vending machines being part of a centrally controlled network of vending machines

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Physics & Mathematics (AREA)
  • Physics & Mathematics (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO953050A 1994-08-04 1995-08-03 Anvendelse av neurotensin-antagonister for fremstilling av diuretiske medikamenter NO307737B1 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9409687A FR2723317B1 (fr) 1994-08-04 1994-08-04 Utilisation d'antagonistes de la neurotensine pour la preparation de medicaments diuretiques

Publications (3)

Publication Number Publication Date
NO953050D0 NO953050D0 (no) 1995-08-03
NO953050L true NO953050L (no) 1996-02-05
NO307737B1 NO307737B1 (no) 2000-05-22

Family

ID=9466082

Family Applications (1)

Application Number Title Priority Date Filing Date
NO953050A NO307737B1 (no) 1994-08-04 1995-08-03 Anvendelse av neurotensin-antagonister for fremstilling av diuretiske medikamenter

Country Status (12)

Country Link
US (1) US5955474A (no)
EP (1) EP0699438A3 (no)
JP (1) JPH0840934A (no)
CN (1) CN1133173A (no)
AU (1) AU704103B2 (no)
CA (1) CA2155245A1 (no)
FI (1) FI953720A (no)
FR (1) FR2723317B1 (no)
IL (1) IL114787A0 (no)
NO (1) NO307737B1 (no)
NZ (1) NZ272717A (no)
ZA (1) ZA956546B (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7923465B2 (en) 2005-06-02 2011-04-12 Glenmark Pharmaceuticals S.A. Cannabinoid receptor ligands, pharmaceutical compositions containing them, and process for their preparation
US7727978B2 (en) 2006-08-24 2010-06-01 Bristol-Myers Squibb Company Cyclic 11-beta hydroxysteroid dehydrogenase type I inhibitors
US8119658B2 (en) 2007-10-01 2012-02-21 Bristol-Myers Squibb Company Triazolopyridine 11-beta hydroxysteroid dehydrogenase type I inhibitors
ES2538002T3 (es) 2009-01-07 2015-06-16 INSERM (Institut National de la Santé et de la Recherche Médicale) Métodos para el tratamiento, la evaluación pronóstica y la detección de cáncer de mama
CN103891742A (zh) * 2014-04-09 2014-07-02 山东农业大学 一种用于人工饲料养蚕的防腐消毒剂

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2263638A (en) * 1992-01-28 1993-08-04 Merck & Co Inc Substituted pyrazoles, isoxazoles and isothiazoles as neurotensin antagonists
GB2263639A (en) * 1992-01-28 1993-08-04 Merck & Co Inc Substituted pyrimidinones as neurotensin antagonists
US5250558A (en) * 1992-01-28 1993-10-05 Merck & Co., Inc. Substituted triazolinones, triazolinethiones, and triazolinimines as neurotensin antagonists used to treat psychosis
GB2263635A (en) * 1992-01-28 1993-08-04 Merck & Co Inc Substitiuted triazoles as neurotensin antagonists
GB2263637A (en) * 1992-01-28 1993-08-04 Merck & Co Inc Substituted imidazo-fused 6-membered carbocycle or heterocycle as neurotensin antagonists
US5204354A (en) * 1992-02-14 1993-04-20 Merck & Co., Inc. Substituted quinazolinones as neurotensin antagonists useful in the treatment of CNS disorders

Also Published As

Publication number Publication date
NO307737B1 (no) 2000-05-22
NO953050D0 (no) 1995-08-03
NZ272717A (en) 1997-04-24
ZA956546B (en) 1996-07-02
US5955474A (en) 1999-09-21
FI953720A0 (fi) 1995-08-04
FI953720A (fi) 1996-02-05
JPH0840934A (ja) 1996-02-13
FR2723317B1 (fr) 1996-10-31
AU2836495A (en) 1996-02-15
EP0699438A2 (en) 1996-03-06
FR2723317A1 (fr) 1996-02-09
EP0699438A3 (en) 1997-06-04
IL114787A0 (en) 1995-11-27
CN1133173A (zh) 1996-10-16
AU704103B2 (en) 1999-04-15
CA2155245A1 (en) 1996-02-05

Similar Documents

Publication Publication Date Title
PT1009732E (pt) 1-amino-alquilciclo-hexanos antagonistas do receptor nmda
ZA98691B (en) Use of central cannabinoid receptor antagonists for the preparation of drugs
DE122010000011I1 (de) Flüssige gonadotropinhaltige Arzneimittel
DK0738150T3 (da) Bicykliske fibrinogene antagonister
BRPI9810519B1 (pt) derivados de 4''-substituìdo-9-desoxo-9a-aza-9a-homoeritromicina a e composição farmacêutica compreendendo os mesmos.
BR9707501A (pt) Composto composição farmacêutica e uso do composto
PT918059E (pt) Derivados substituidos de imidazolidina a sua sintese a sua utilizacao e preparacoes farmaceuticas contendo os mesmos
DE69737936D1 (de) Arzneimittel
NO20040145L (no) Anvendelse av benzensulfonamidderivater for fremstilling av et medikament
EE9900086A (et) Bensamidiini derivaadid ja nende kasutamine LTB-4 antagonistliku mõjuga ravimitena
FI990134A (fi) Pyridatsino-(4,5-beta)-kinoliini-5-oksidijohdannaisia, niiden valmistus ja niiden käyttö glysiiniantagonisteina
ID19245A (id) Antagonis reseptor vitronektin, pembuatannya dan pemakaiannya
BR9612413A (pt) Composto uso do mesmo e composição farmacêutica
FI964619A0 (fi) Epilepsialääkkeiden iholle annostelu
PT964867E (pt) Antagonistas da taquicinima
IS4597A (is) Ný lyfjafræðileg notkun AII-viðtaka mótlyfja
NO953050L (no) Anvendelse av neurotensin-antagonister for fremstilling av diuretiske medikamenter
FI973230A0 (fi) Uusi farmaseuttinen formulaatio
FI971317A (fi) Uusia heterosyklisiä, substituoituja imidatsolokinoksalinoneja, niiden valmistus ja käyttö
FI951155A (fi) Farmaseuttinen valmiste
DE9414208U1 (de) Beschlagunterteil
DE59805373D1 (de) Nephroprotektive Arzneimittel
FI965186A (fi) 1,2,5,6-Tetrahydropyridiinijohdannaisten käyttö rauhoittavien lääkkeide valmistamiseksi
DE29618094U1 (de) Pharmazeutisches Präparat
EE03762B1 (et) Protsess NMDA antagonistide valmistamiseks